Home > Products > CD64 & HIV-1 gp41 > Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (sdAb-IgG)

Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (sdAb-IgG)  (CAT#: BSSG-393)

Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (sdAb-IgG) is formed by an IgG and two single domains antibodies (sdAbs). The sdAbs from an anti-HIV-1 gp41 antibody variable domain are respectively connected to the N terminus of the anti-CD64 IgG heavy chains or light chains to form sdAb-(H)IgG or sdAb-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget neutrophils cells to HIV-1 infected cells. It is designed for the research of HIV-1 infection, AIDS therapy.
Datasheet INQUIRY

Specifications

Targets
CD64 & HIV-1 gp41
Type
sdAb-IgG
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
HIV-1 infection, AIDS
Host Animal 1
Mouse
Host Animal 2
llama

Targets

Target 1
CD64
Gene ID
UniProt ID
Alternative Names
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Target 2
HIV-1 gp41
Gene ID
UniProt ID
Alternative Names
ENV; gp160; Envelope glycoprotein 120; envelope glycoprotein; Envelope surface glycoprotein gp160, precursor; hypothetical protein; Envelope surface glycoprotein gp120; Envelope transmembrane domain; human immunodeficiency virus type 1; human immunodeficiency virus type 1 gp120; human immunodeficiency virus type 1 glycoprotein 120; gp41; GP41; glycoprotein 41
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD64 & HIV-1 gp41"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (sdAb-IgG) (BSSG-393). Click the button below to contact us or submit your feedback about this product.